Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification

Overview of attention for article published in Immunogenetics, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 1,231)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 1 X user

patent: 21 patents

Readers on

mendeley: 291 Mendeley

Summary X Patents

So far, Altmetric has seen 21 patents that reference this research output.

RNA AND DNA BASE EDITING VIA ENGINEERED ADAR RECRUITMENT

Application EP-4332224-A2

European Patent Office

Reducing junction epitope presentation for neoantigens

Grant US-11885815-B2

United States of America

Therapeutic editing

Grant US-11827880-B2

United States of America

Neoantigen identification using hotspots

Grant US-11264117-B2

United States of America

Neoantigen identification, manufacture, and use

Grant US-11183286-B2

United States of America

NEOANTIGEN IDENTIFICATION, MANUFACTURE, AND USE

Application EP-3635594-A4

European Patent Office

METHODS FOR IDENTIFYING AND USING DISEASE-ASSOCIATED ANTIGENS

Application WO-2020243469-A1

World Intellectual Property Organisation (WIPO)

Neoantigen identification, manufacture, and use

Grant US-10847253-B2

United States of America

Neoantigen identification, manufacture, and use

Grant US-10847252-B2

United States of America

METHODS FOR PRE-SELECTION OF NEOEPITOPES

Application WO-2020221783-A1

World Intellectual Property Organisation (WIPO)

Identification, production, and use of nascent antigens

Application JP-2020519246-A

Japan

NEOANTIGEN IDENTIFICATION, MANUFACTURE, AND USE

Application EP-3635594-A1

European Patent Office

METHOD FOR SELECTING NEOEPITOPES

Application WO-2020065023-A1

World Intellectual Property Organisation (WIPO)

ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER

Application WO-2020022903-A1

World Intellectual Property Organisation (WIPO)

CANCER VACCINES FOR COLORECTAL CANCER

Application WO-2020022902-A1

World Intellectual Property Organisation (WIPO)

CANCER VACCINES FOR BREAST CANCER

Application WO-2020022899-A1

World Intellectual Property Organisation (WIPO)

CANCER VACCINES FOR UTERINE CANCER

Application WO-2020022901-A1

World Intellectual Property Organisation (WIPO)

CANCER VACCINES FOR KIDNEY CANCER

Application WO-2020022900-A1

World Intellectual Property Organisation (WIPO)

Identification, production and use of novel antigens

Application CN-110720127-A

China

DIAGNOSTIC METHOD AND THERAPY

Application WO-2019211633-A1

World Intellectual Property Organisation (WIPO)

T CELL EPITOPE PEPTIDE COMBINATIONS OF CRY J 1 AND CRY J 2 AND USE THEREOF IN TREATING…

Application WO-2016209959-A3

World Intellectual Property Organisation (WIPO)